What is the expected growth rate of the smoking cessation aids market?
The global smoking cessation aids market is expected to grow at a significant CAGR of 16.9% during the forecast period (2022-2029). This growth is driven by rising awareness about the harmful effects of smoking, increasing government initiatives to curb tobacco use, and the introduction of new and innovative smoking cessation products.
Who are the major players in the smoking cessation aids market?
Some of the major players in the global smoking cessation aids market include Takeda Pharmaceutical Company Limited, NJOY, Pfizer Inc, Cipla Ltd, GlaxoSmithKline Plc, Dr Reddy's Laboratories, Juul Labs, Glenmark, Perrigo Company plc, Johnson and Johnson Services, Inc, and Imperial Brands.